DOI: 10.1055/s-00000011

DMW - Deutsche Medizinische Wochenschrift

References

Ridker PM, MacFadyen JG, Everett BM. CANTOS Trial Group. et al.
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomized controlled trial.

Lancet 2018;
391: 319-328

Download Bibliographical Data

Search in:
Access: